Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Be Biopharma develops engineered B cell medicines for serious genetic diseases.
Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.
Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Bia Energy is transforming LatAm’s power sector with smart meters and a digital platform for real-time control, savings, and sustainability.
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.
Game Play Network is a real money gaming platform that offers online racing casino for players.
Lusaris Therapeutics develops small-molecule neuroplastogen therapeutics for neuropsychiatric and neurological disorders.
Sortera Alloys manufactures low-cost, high-quality metal alloys for domestic manufacturing using its artificial intelligence technology.
Cortica provides neurological therapies for children with autism and other developmental differences.
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.
Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.
Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Ervaxx is illuminating the immune interface to develop new cancer therapies.
Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.
Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
RA Capital Management has invested in 453 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Therapeutics, Health Care, Biopharma, Pharmaceutical. The firm invests across 30 different industry categories.
Among tracked funding rounds, Cidara Therapeutics received $339.0M in a Grant round. RA Capital Management's total known invested capital is $44.2B.
RA Capital Management's average investment size is $123.1M across its portfolio of 453 companies.
Recent RA Capital Management portfolio additions include Be Biopharma, Azalea Therapeutics, Antios Therapeutics, Verve Therapeutics, Bia Energy. These companies were founded in 2020 or later.